These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16843168)

  • 1. Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications.
    Seo D; Ginsburg GS; Goldschmidt-Clermont PJ
    J Am Coll Cardiol; 2006 Jul; 48(2):227-35. PubMed ID: 16843168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gene expression profiling in genetic and multifactorial cardiovascular diseases.
    Nanni L; Romualdi C; Maseri A; Lanfranchi G
    J Mol Cell Cardiol; 2006 Dec; 41(6):934-48. PubMed ID: 17020763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic and proteomic analysis in the cardiovascular setting: unravelling the disease?
    Marziliano N; Grasso M; Pilotto A; Porcu E; Tagliani M; Disabella E; Diegoli M; Pasotti M; Favalli V; Serio A; Gambarin F; Tavazzi L; Klersy C; Arbustini E
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):433-42. PubMed ID: 19449458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiling of cardiovascular disease.
    Archacki S; Wang Q
    Hum Genomics; 2004 Aug; 1(5):355-70. PubMed ID: 15588496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiomics Analysis Coupled with Text Mining Identify Novel Biomarker Candidates for Recurrent Cardiovascular Events.
    Chalikiopoulou C; Bizjan BJ; Leventopoulos G; Smaili K; Blagus T; Menti A; Liopetas J; John A; Ali BR; Dolzan V; Hahalis GN; Patrinos GP; Katsila T
    OMICS; 2020 Apr; 24(4):205-215. PubMed ID: 32176569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics.
    Podgoreanu MV; Schwinn DA
    J Am Coll Cardiol; 2005 Dec; 46(11):1965-77. PubMed ID: 16325027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic and cytogenetic evaluation in CYP2C19*2 and CYP2C19*3 allelomorphism in South Indian population with clopidogrel therapy.
    Tantray JA; Reddy KP; Jamil K; Kumar YS
    Int J Cardiol; 2017 Feb; 229():113-118. PubMed ID: 27915083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress of gene expression profile of cardiovascular diseases].
    Wang RL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):483-5. PubMed ID: 16134614
    [No Abstract]   [Full Text] [Related]  

  • 9. An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis.
    Marchetti G; Girelli D; Zerbinati C; Lunghi B; Friso S; Meneghetti S; Coen M; Gagliano T; Guastella G; Bochaton-Piallat ML; Pizzolo F; Mascoli F; Malerba G; Bovolenta M; Ferracin M; Olivieri O; Bernardi F; Martinelli N
    Thromb Haemost; 2015 Mar; 113(3):655-63. PubMed ID: 25374339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray, SAGE and their applications to cardiovascular diseases.
    Ye SQ; Lavoie T; Usher DC; Zhang LQ
    Cell Res; 2002 Jun; 12(2):105-15. PubMed ID: 12118936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration--a key to success in the genetic dissection of complex diseases?
    Yagil Y; Yagil C
    Trends Cardiovasc Med; 2006 Feb; 16(2):35-8. PubMed ID: 16473759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray analysis of cardiovascular diseases.
    Archacki SR; Wang QK
    Methods Mol Med; 2006; 129():1-13. PubMed ID: 17085801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics of cardiovascular pharmacology: pharmacogenomic network of cardiovascular disease models.
    Tanaka T; Oka T; Shimada Y; Umemoto N; Kuroyanagi J; Sakamoto C; Zang L; Wang Z; Nishimura Y
    J Pharmacol Sci; 2008 May; 107(1):8-14. PubMed ID: 18490853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Management of Cardiovascular Disorders.
    Jain KK
    Med Princ Pract; 2017; 26(5):399-414. PubMed ID: 28898880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of gene expression profiling to cardiovascular disease.
    Henriksen PA; Kotelevtsev Y
    Cardiovasc Res; 2002 Apr; 54(1):16-24. PubMed ID: 12062357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA microarrays: implications for cardiovascular medicine.
    Cook SA; Rosenzweig A
    Circ Res; 2002 Oct; 91(7):559-64. PubMed ID: 12364382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic testing in polygenic diseases : Atrial fibrillation, arterial hypertension and coronary artery disease].
    Trenkwalder T; Kessler T; Schunkert H
    Herz; 2017 Aug; 42(5):440-448. PubMed ID: 28536780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of industrial scale genomics to discovery of therapeutic targets in heart failure.
    Mehraban F; Tomlinson JE
    Eur J Heart Fail; 2001 Dec; 3(6):641-50. PubMed ID: 11738215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressed genome molecular signatures of heart failure.
    Liew CC
    Clin Chem Lab Med; 2005; 43(5):462-9. PubMed ID: 15899667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis in cardiovascular disease: a clinical perspective.
    Ho E; Bhindi R; Ashley EA; Figtree GA
    Cardiol Rev; 2011; 19(2):81-9. PubMed ID: 21285668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.